Evidence map›Paper›PMID 32040721›Full record

ArticleRadiation and environmental biophysics2020

Radiation-induced circulating miRNA expression in blood of head and neck cancer patients.

Francesca Pasi, Franco Corbella, Ambrogia Baio, Enrica Capelli, Annalisa De Silvestri, Carmine Tinelli, Rosanna Nano

Abstract read
PubMed Publisher
In one paragraph

Article in Radiation and environmental biophysics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Role and mechanism of miR-187 in human cancer.American journal of translational research · 2020
    Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Francesca PasiRadiotherapy Unit, Department of Oncohaematology, Fondazione IRCCS Policlinico San Matteo, Viale Golgi 19, Pavia, Italy. f.pasi@smatteo.pv.it.ORCID 0000-0003-3310-2890
Franco CorbellaRadiotherapy Unit, Department of Oncohaematology, Fondazione IRCCS Policlinico San Matteo, Viale Golgi 19, Pavia, Italy.
Ambrogia BaioRadiotherapy Unit, Department of Oncohaematology, Fondazione IRCCS Policlinico San Matteo, Viale Golgi 19, Pavia, Italy.
Enrica CapelliDepartment of Earth and Environmental Sciences, Laboratory of Immunology and Genetic Analysis, University of Pavia, Via Taramelli 21, Pavia, Italy.
Annalisa De SilvestriBiometry and Medical Statistics, Policlinico San Matteo di Pavia, Pavia, Italy.
Carmine TinelliBiometry and Medical Statistics, Policlinico San Matteo di Pavia, Pavia, Italy.
Rosanna NanoDepartment of Biology and Biotechnology "Lazzaro Spallanzani", University of Pavia, Via Ferrata 9, Pavia, Italy.
Policlinico San Matteo Fondazione · ITUniversity of Pavia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, scientists have found evidence confirming the aberrant expression of miRNAs in cancer patients compared to healthy individuals. The growing interest in the identification of non-invasive and specific diagnostic and prognostic molecular markers has identified microRNAs as potential candidates in cancer diagnosis, prognosis and treatment response. In the present study, we have analyzed the expression profile of circulating miR-21, -191 and -421 in peripheral blood of head and neck cancer patients (HNC) to investigate a possible modulation of mRNA levels by radiation and to identify the role of mRNA as biomarkers of cancer prognosis. Results showed a modulation of the microRNA expression at different time points after radiotherapy, suggesting that treatment may influence the release of circulating miRNAs depending also on the time interval elapsed since radiotherapy. The expression levels of miR-21, -191 and -421 were higher in blood of patients treated with radiotherapy alone after 6 months from the end of therapy and high levels of them seemed to correlate with the remission of the disease. The trends shown in this study confirmed that miRNAs could be useful prognosis markers and could provide preliminary data for further evaluation in predicting patients' response to radiotherapy by developing miRNA-based treatments to improve the sensitivity of cancer cells to radiotherapy.

Indexed as

AgedAged, 80 and overBiomarkersCarcinoma, Squamous CellHead and Neck NeoplasmsHumansMaleMicroRNAsMiddle AgedParticle AcceleratorsPrognosisX-RaysBiomarkersMicroRNAsHead and neck cancermiRNARadiation

Identifiers

PMID32040721
OpenAlexW3005828565

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.